vs
嘉德诺（BTSG）与Ross Stores（ROST）财务数据对比。点击上方公司名可切换其他公司
Ross Stores的季度营收约是嘉德诺的1.6倍（$5.6B vs $3.6B），Ross Stores净利率更高（9.1% vs 2.2%，领先7.0%），嘉德诺同比增速更快（16.3% vs 10.4%），Ross Stores自由现金流更多（$617.8M vs $193.9M），过去两年嘉德诺的营收复合增速更高（17.4% vs -3.6%）
嘉德诺是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品与医疗产品分销，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医用外科用品，还运营着规模位居前列的放射性药物网络。
Ross Stores, Inc.是美国知名折扣百货连锁集团，旗下核心品牌为Ross Dress for Less，总部位于加利福尼亚州都柏林，是美国规模最大的平价零售商。截至2024年7月，集团在全美43个州、华盛顿特区、波多黎各及关岛共运营1795家门店，暂未覆盖新英格兰地区及阿拉斯加，另拥有门店数超353家的折扣零售品牌DD's Discounts。
BTSG vs ROST — 直观对比
营收规模更大
ROST
是对方的1.6倍
$3.6B
营收增速更快
BTSG
高出5.9%
10.4%
净利率更高
ROST
高出7.0%
2.2%
自由现金流更多
ROST
多$423.9M
$193.9M
两年增速更快
BTSG
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.6B | $5.6B |
| 净利润 | $77.1M | $511.9M |
| 毛利率 | 11.6% | 28.0% |
| 营业利润率 | 3.0% | 11.6% |
| 净利率 | 2.2% | 9.1% |
| 营收同比 | 16.3% | 10.4% |
| 净利润同比 | 381.8% | 4.7% |
| 每股收益（稀释后） | $0.34 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BTSGROST
| Q4 25 | $3.6B | $5.6B | ||
| Q3 25 | $3.3B | $5.5B | ||
| Q2 25 | $3.1B | $5.0B | ||
| Q1 25 | $2.9B | $5.9B | ||
| Q4 24 | $3.1B | $5.1B | ||
| Q3 24 | $2.9B | $5.3B | ||
| Q2 24 | $2.7B | $4.9B | ||
| Q1 24 | $2.6B | $6.0B |
净利润BTSGROST
| Q4 25 | $77.1M | $511.9M | ||
| Q3 25 | $55.8M | $508.0M | ||
| Q2 25 | $28.2M | $479.2M | ||
| Q1 25 | $29.5M | $586.8M | ||
| Q4 24 | $16.0M | $488.8M | ||
| Q3 24 | $-8.2M | $527.1M | ||
| Q2 24 | $19.9M | $488.0M | ||
| Q1 24 | $-45.8M | $609.7M |
毛利率BTSGROST
| Q4 25 | 11.6% | 28.0% | ||
| Q3 25 | 11.8% | 27.6% | ||
| Q2 25 | 11.9% | 28.2% | ||
| Q1 25 | 11.8% | 26.5% | ||
| Q4 24 | 13.8% | 28.3% | ||
| Q3 24 | 14.0% | 28.3% | ||
| Q2 24 | 14.2% | 28.1% | ||
| Q1 24 | 14.3% | 27.3% |
营业利润率BTSGROST
| Q4 25 | 3.0% | 11.6% | ||
| Q3 25 | 2.6% | 11.5% | ||
| Q2 25 | 1.5% | 12.2% | ||
| Q1 25 | 1.8% | 12.4% | ||
| Q4 24 | 2.6% | 11.9% | ||
| Q3 24 | 2.0% | 12.5% | ||
| Q2 24 | 2.3% | 12.2% | ||
| Q1 24 | 0.3% | 13.2% |
净利率BTSGROST
| Q4 25 | 2.2% | 9.1% | ||
| Q3 25 | 1.7% | 9.2% | ||
| Q2 25 | 0.9% | 9.6% | ||
| Q1 25 | 1.0% | 9.9% | ||
| Q4 24 | 0.5% | 9.6% | ||
| Q3 24 | -0.3% | 10.0% | ||
| Q2 24 | 0.7% | 10.0% | ||
| Q1 24 | -1.8% | 10.1% |
每股收益（稀释后）BTSGROST
| Q4 25 | $0.34 | $1.58 | ||
| Q3 25 | $0.26 | $1.56 | ||
| Q2 25 | $0.13 | $1.47 | ||
| Q1 25 | $0.14 | $1.79 | ||
| Q4 24 | $0.11 | $1.48 | ||
| Q3 24 | $-0.04 | $1.59 | ||
| Q2 24 | $0.10 | $1.46 | ||
| Q1 24 | $-0.26 | $1.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.4M | $4.1B |
| 总债务越低越好 | $2.5B | $1.5B |
| 股东权益账面价值 | $1.9B | $5.9B |
| 总资产 | $6.4B | $15.4B |
| 负债/权益比越低杠杆越低 | 1.34× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BTSGROST
| Q4 25 | $88.4M | $4.1B | ||
| Q3 25 | $140.3M | $3.8B | ||
| Q2 25 | $70.1M | $3.8B | ||
| Q1 25 | $52.3M | $4.7B | ||
| Q4 24 | $61.3M | $4.3B | ||
| Q3 24 | $36.0M | $4.7B | ||
| Q2 24 | $25.0M | $4.7B | ||
| Q1 24 | $58.0M | $4.9B |
总债务BTSGROST
| Q4 25 | $2.5B | $1.5B | ||
| Q3 25 | $2.5B | $1.5B | ||
| Q2 25 | $2.5B | $1.5B | ||
| Q1 25 | $2.5B | $2.2B | ||
| Q4 24 | $2.6B | $2.2B | ||
| Q3 24 | $2.7B | $2.5B | ||
| Q2 24 | $2.6B | $2.5B | ||
| Q1 24 | $2.6B | $2.5B |
股东权益BTSGROST
| Q4 25 | $1.9B | $5.9B | ||
| Q3 25 | $1.8B | $5.7B | ||
| Q2 25 | $1.7B | $5.6B | ||
| Q1 25 | $1.7B | $5.5B | ||
| Q4 24 | $1.6B | $5.3B | ||
| Q3 24 | $1.6B | $5.1B | ||
| Q2 24 | $1.6B | $4.9B | ||
| Q1 24 | $1.6B | $4.9B |
总资产BTSGROST
| Q4 25 | $6.4B | $15.4B | ||
| Q3 25 | $6.0B | $14.5B | ||
| Q2 25 | $5.9B | $14.3B | ||
| Q1 25 | $5.8B | $14.9B | ||
| Q4 24 | $5.9B | $14.9B | ||
| Q3 24 | $5.8B | $14.7B | ||
| Q2 24 | $5.6B | $14.5B | ||
| Q1 24 | $5.7B | $14.3B |
负债/权益比BTSGROST
| Q4 25 | 1.34× | 0.26× | ||
| Q3 25 | 1.38× | 0.26× | ||
| Q2 25 | 1.45× | 0.27× | ||
| Q1 25 | 1.50× | 0.40× | ||
| Q4 24 | 1.58× | 0.42× | ||
| Q3 24 | 1.65× | 0.48× | ||
| Q2 24 | 1.63× | 0.50× | ||
| Q1 24 | 1.64× | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $231.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $193.9M | $617.8M |
| 自由现金流率自由现金流/营收 | 5.5% | 11.0% |
| 资本支出强度资本支出/营收 | 1.1% | 3.7% |
| 现金转化率经营现金流/净利润 | 3.00× | 1.62× |
| 过去12个月自由现金流最近4个季度 | $394.7M | $2.0B |
8季度趋势，按日历期对齐
经营现金流BTSGROST
| Q4 25 | $231.6M | $827.1M | ||
| Q3 25 | $107.9M | $668.4M | ||
| Q2 25 | $49.1M | $409.7M | ||
| Q1 25 | $101.6M | $882.6M | ||
| Q4 24 | $90.6M | $513.4M | ||
| Q3 24 | $27.2M | $592.1M | ||
| Q2 24 | $-15.2M | $368.9M | ||
| Q1 24 | $-78.9M | $948.8M |
自由现金流BTSGROST
| Q4 25 | $193.9M | $617.8M | ||
| Q3 25 | $92.2M | $466.6M | ||
| Q2 25 | $24.7M | $202.3M | ||
| Q1 25 | $84.0M | $676.6M | ||
| Q4 24 | $75.3M | $333.0M | ||
| Q3 24 | $7.2M | $394.6M | ||
| Q2 24 | $-39.0M | $232.7M | ||
| Q1 24 | $-100.7M | $726.4M |
自由现金流率BTSGROST
| Q4 25 | 5.5% | 11.0% | ||
| Q3 25 | 2.8% | 8.4% | ||
| Q2 25 | 0.8% | 4.1% | ||
| Q1 25 | 2.9% | 11.4% | ||
| Q4 24 | 2.5% | 6.6% | ||
| Q3 24 | 0.2% | 7.5% | ||
| Q2 24 | -1.4% | 4.8% | ||
| Q1 24 | -3.9% | 12.1% |
资本支出强度BTSGROST
| Q4 25 | 1.1% | 3.7% | ||
| Q3 25 | 0.5% | 3.6% | ||
| Q2 25 | 0.8% | 4.2% | ||
| Q1 25 | 0.6% | 3.5% | ||
| Q4 24 | 0.5% | 3.6% | ||
| Q3 24 | 0.7% | 3.7% | ||
| Q2 24 | 0.9% | 2.8% | ||
| Q1 24 | 0.8% | 3.7% |
现金转化率BTSGROST
| Q4 25 | 3.00× | 1.62× | ||
| Q3 25 | 1.93× | 1.32× | ||
| Q2 25 | 1.74× | 0.85× | ||
| Q1 25 | 3.44× | 1.50× | ||
| Q4 24 | 5.66× | 1.05× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | -0.76× | 0.76× | ||
| Q1 24 | — | 1.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
ROST
暂无分部数据
